Trivalent Influenza virus vaccine(MDCK cell) (Chengdu Oulin/Lanzhou Bailing/Chengdu Xinnoming)

三价流感病毒裂解疫苗（MDCK细胞）（成都欧林/兰州百灵/成都新诺明）

Report date: 2024/10/22 11:19:16

Base Information

Drug NameTrivalent Influenza virus vaccine(MDCK cell) (Chengdu Oulin/Lanzhou Bailing/Chengdu Xinnoming)
Drug Alias NameN/A
ClassificationVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChengdu Oulin Biological Science & Technology Co LtdLanzhou Bailing Biotechnology Co LtdChengdu Xinnoming Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Oulin Biological Science & Technology Co LtdLanzhou Bailing Biotechnology Co LtdChengdu Xinnoming Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A